MARIOTTO, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 1.381
AS - Asia 262
EU - Europa 211
SA - Sud America 2
Totale 1.856
Nazione #
US - Stati Uniti d'America 1.372
SG - Singapore 119
CN - Cina 114
IT - Italia 89
DE - Germania 27
FI - Finlandia 24
FR - Francia 23
GB - Regno Unito 17
IN - India 13
VN - Vietnam 12
CA - Canada 9
SE - Svezia 8
NL - Olanda 5
UA - Ucraina 5
ES - Italia 4
RU - Federazione Russa 3
BR - Brasile 2
IE - Irlanda 2
KR - Corea 2
AT - Austria 1
BG - Bulgaria 1
ID - Indonesia 1
KG - Kirghizistan 1
LV - Lettonia 1
PL - Polonia 1
Totale 1.856
Città #
Fairfield 209
Chandler 114
Woodbridge 112
Ashburn 111
Seattle 101
Cambridge 91
Singapore 90
Houston 85
Ann Arbor 68
Wilmington 61
Santa Clara 52
Boardman 39
San Diego 31
Des Moines 24
Medford 24
Princeton 24
Helsinki 20
Roxbury 20
Padova 19
Beijing 18
Dong Ket 9
Jinan 9
North York 9
Hefei 7
London 7
Nanjing 7
Cagliari 6
Falls Church 6
Ogden 6
Anagni 4
Hebei 4
Rovigo 4
Shenyang 4
Calvisano 3
Chicago 3
Guangzhou 3
Hangzhou 3
Hanoi 3
Kilburn 3
Lappeenranta 3
Milan 3
Nanchang 3
Rome 3
Shanghai 3
Susegana 3
Afragola 2
Agna 2
Badia Calavena 2
Bolgare 2
Changsha 2
Dublin 2
Foggia 2
Grafing 2
Hilversum 2
Islington 2
Kharkiv 2
Kunming 2
Madrid 2
Moncada 2
Munich 2
New York 2
Norwalk 2
Nürnberg 2
Paris 2
Pozzuolo Martesana 2
Pune 2
Spinea 2
Tianjin 2
Vicenza 2
Acton 1
Agordo 1
Amsterdam 1
Aracaju 1
Bishkek 1
Breganze 1
Campagna Lupia 1
Chiswick 1
Dallas 1
Delhi 1
Falkenstein 1
Florence 1
Forest City 1
Foshan 1
Gangnam-gu 1
Genoa 1
Haikou 1
Jakarta 1
Jandira 1
Jiaxing 1
Kolkata 1
La Canada Flintridge 1
Lanzhou 1
Leawood 1
Los Angeles 1
Mahbubnagar 1
Nerviano 1
New Bedfont 1
Pantigliate 1
Perugia 1
Phoenix 1
Totale 1.510
Nome #
AKR1C enzymes sustain therapy resistance in paediatric T-ALL 140
Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2- d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors 132
Choline kinase alpha inhibition by EB-3D triggers cellular senescence, reduces tumor growth and metastatic dissemination in breast cancer 129
EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells 126
Lead optimization-hit expansion of new asymmetrical pyridinium/quinolinium compounds as choline kinase α1 inhibitors 102
TP-0903 inhibits neuroblastoma cell growth and enhances the sensitivity to conventional chemotherapy 100
SYK targeting represents a potential therapeutic option for relapsed resistant pediatric ETV6-RUNX1 B-acute lymphoblastic leukemia patients 92
New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1 87
A BAG's life: Every connection matters in cancer 75
In vitro and in vivo antitumor activity of new choline kinase inhibitor: a pharmacological strategy for breast cancer and leukemia treatment. 75
Design and synthesis of potent in vitro and in vivo anticancer agents based on 1-(3',4',5'-trimethoxyphenyl)-2-Aryl-1H-imidazole 66
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents 64
Design, synthesis, in vitro and in vivo biological evaluation of 2-amino-3-aroylbenzo[b]furan derivatives as highly potent tubulin polymerization inhibitors 64
Design, synthesis and biological evaluation of novel vicinal diaryl-substituted 1H-Pyrazole analogues of combretastatin A-4 as highly potent tubulin polymerization inhibitors 61
Autophagic flux inhibition enhances cytotoxicity of the receptor tyrosine kinase inhibitor ponatinib 61
Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1) 57
Synthesis, biological evaluation, in silico modeling and crystallization of novel small monocationic molecules with potent antiproliferative activity by dual mechanism 47
Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems 46
BAG1 down-regulation increases chemo-sensitivity of acute lymphoblastic leukaemia cells 45
A facile synthesis of diaryl pyrroles led to the discovery of potent colchicine site antimitotic agents 42
Cinnamic acid derivatives linked to arylpiperazines as novel potent inhibitors of tyrosinase activity and melanin synthesis 33
Anticancer and structure activity relationship of non-symmetrical choline kinase inhibitors 30
Design, Synthesis and Biological Investigation of 2-Anilino Triazolopyrimidines as Tubulin Polymerization Inhibitors with Anticancer Activities 26
Design, Synthesis and Biological Investigation of 2-Anilino Triazolopyrimidines as Tubulin Polymerization Inhibitors with Anticancer Activities 24
Synthesis and Biological Evaluation of Highly Active 7-Anilino Triazolopyrimidines as Potent Antimicrotubule Agents 24
Histone Deacetylase Inhibitors Impair Glioblastoma Cell Motility and Proliferation 22
Design, synthesis and biological evaluation of novel 2,4-thiazolidinedione derivatives able to target the human BAG3 protein 21
Identification of Homoharringtonine as a potent inhibitor of glioblastoma cell proliferation and migration 20
New bioisosteric sulphur-containing choline kinase inhibitors with a tracked mode of action 20
Biological Evaluation of New Thienopyridinium and Thienopyrimidinium Derivatives as Human Choline Kinase Inhibitors 20
New bioisosteric sulphur-containing choline kinase inhibitors with a tracked mode of action 14
HLA Class II Antibody Activation of Endothelial Cells Promotes Th17 and Disrupts Regulatory T Lymphocyte Expansion 11
Molecular and functional profiling of chemotolerant cells unveils nucleoside metabolism-dependent vulnerabilities in medulloblastoma 9
Synthesis and Biological Evaluation of Novel 2-Aroyl Benzofuran-Based Hydroxamic Acids as Antimicrotubule Agents 7
Potent In Vitro and In Vivo Anticancer Activity of New Bipyridine and Bipyrimidine Gold (III) Dithiocarbamate Derivatives 7
Totale 1.899
Categoria #
all - tutte 9.445
article - articoli 9.173
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.618


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020294 0 0 0 0 26 28 45 34 48 57 36 20
2020/2021318 17 45 17 39 11 10 6 21 40 30 47 35
2021/2022360 1 7 69 15 21 20 30 46 20 22 41 68
2022/2023272 48 21 2 34 31 42 4 19 30 15 22 4
2023/2024211 5 39 27 25 17 7 19 9 8 16 17 22
2024/2025283 6 112 39 49 77 0 0 0 0 0 0 0
Totale 1.899